Arrowhead Pharmaceuticals Net Profit Margin 2006-2020 | ARWR

Arrowhead Pharmaceuticals net profit margin from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Arrowhead Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.12B $-0.03B -20.33%
2020-03-31 $0.14B $0.01B 6.47%
2019-12-31 $0.16B $0.05B 32.52%
2019-09-30 $0.17B $0.07B 40.24%
2019-06-30 $0.14B $0.05B 32.85%
2019-03-31 $0.10B $0.01B 9.47%
2018-12-31 $0.05B $-0.03B -62.50%
2018-09-30 $0.02B $-0.06B -323.53%
2018-06-30 $0.02B $-0.06B -366.67%
2018-03-31 $0.02B $-0.05B -195.65%
2017-12-31 $0.03B $-0.04B -116.13%
2017-09-30 $0.03B $-0.04B -112.90%
2017-06-30 $0.02B $-0.05B -209.09%
2017-03-31 $0.01B $-0.06B -453.85%
2016-12-31 $0.00B $-0.07B -1850.00%
2016-09-30 $0.00B $-0.08B inf%
2016-06-30 $0.00B $-0.08B inf%
2016-03-31 $0.00B $-0.08B inf%
2015-12-31 $0.00B $-0.09B inf%
2015-09-30 $0.00B $-0.09B inf%
2015-06-30 $0.00B $-0.09B inf%
2015-03-31 $0.00B $-0.09B inf%
2014-12-31 $0.00B $-0.07B inf%
2014-09-30 $0.00B $-0.06B inf%
2014-06-30 $0.00B $-0.05B inf%
2014-03-31 $0.00B $-0.05B inf%
2013-12-31 $0.00B $-0.04B inf%
2013-09-30 $0.00B $-0.03B inf%
2013-06-30 $0.00B $-0.02B inf%
2013-03-31 $0.00B $-0.03B inf%
2012-12-31 $0.00B $-0.02B inf%
2012-09-30 $0.00B $-0.02B inf%
2009-12-31 $0.00B $-0.01B -433.33%
2009-09-30 $0.00B $-0.02B -475.00%
2009-06-30 $0.00B $-0.03B -625.00%
2009-03-31 $0.00B $-0.03B -3000.00%
2008-12-31 $0.00B $-0.03B -1550.00%
2008-09-30 $0.00B $-0.03B -2800.00%
2008-06-30 $0.00B $-0.03B -1350.00%
2008-03-31 $0.00B $-0.03B -1033.33%
2007-12-31 $0.00B $-0.03B -1550.00%
2007-09-30 $0.00B $-0.03B -1500.00%
2007-06-30 $0.00B $-0.03B -2900.00%
2007-03-31 $0.00B $-0.02B inf%
2006-12-31 $0.00B $-0.02B inf%
2006-09-30 $0.00B $-0.02B inf%
2006-06-30 $0.00B $-0.02B inf%
2006-03-31 $0.00B $-0.01B inf%
2005-12-31 $0.00B $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.480B $0.169B
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.741B 43.65
Takeda Pharmaceutical (TAK) Japan $58.610B 10.21
Astellas Pharma (ALPMY) Japan $28.578B 14.48
Eisai (ESALY) Japan $26.827B 22.67
UCB SA (UCBJF) Belgium $22.446B 0.00
Merck (MKGAF) Germany $18.966B 24.87
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $14.011B 45.54
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Grifols, S.A (GRFS) Spain $10.808B 13.21
Neurocrine Biosciences (NBIX) United States $9.319B 36.08
IPSEN SA ADR (IPSEY) France $9.086B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.720B 12.77
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $7.092B 44.93
Orion OYJ (ORINY) Finland $7.077B 24.56
United Therapeutics (UTHR) United States $4.543B 10.50
Evotec AG (EVTCY) Germany $4.014B 139.34
FibroGen (FGEN) United States $3.961B 0.00
ChemoCentryx (CCXI) United States $3.640B 0.00
Nektar Therapeutics (NKTR) United States $3.560B 0.00
Hypermarcas (HYPMY) Brazil $3.553B 13.07
Sage Therapeutics (SAGE) United States $3.215B 0.00
PTC Therapeutics (PTCT) United States $3.122B 0.00
Pacira BioSciences (PCRX) United States $2.586B 67.98
Xencor (XNCR) United States $2.224B 0.00
Revolution Medicines (RVMD) United States $2.191B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.141B 10.36
Corcept Therapeutics (CORT) United States $2.059B 18.96
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.871B 0.00
Cronos Group (CRON) Canada $1.858B 0.00
USANA Health Sciences (USNA) United States $1.604B 15.11
Ironwood Pharmaceuticals (IRWD) United States $1.549B 10.76
Heron Therapeutics (HRTX) United States $1.410B 0.00
Indivior (INVVY) United States $1.348B 16.71
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.304B 12.43
Trillium Therapeutics (TRIL) Canada $1.271B 0.00
Zogenix (ZGNX) United States $1.252B 0.00
Karyopharm Therapeutics (KPTI) United States $1.194B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.082B 0.00
Esperion Therapeutics (ESPR) United States $1.041B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Translate Bio (TBIO) United States $0.984B 0.00
VAXART, INC (VXRT) United States $0.956B 0.00
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.894B 556.75
Endo (ENDP) Ireland $0.722B 1.07
Tilray (TLRY) Canada $0.682B 0.00
ImmunoGen (IMGN) United States $0.674B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.672B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.666B 0.00
Collegium Pharmaceutical (COLL) United States $0.625B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.587B 0.00
Siga Technologies (SIGA) United States $0.567B 60.50
Aerie Pharmaceuticals (AERI) United States $0.563B 0.00
Radius Health (RDUS) United States $0.547B 0.00
Ocular Therapeutix (OCUL) United States $0.547B 0.00
Flexion Therapeutics (FLXN) United States $0.546B 0.00
Molecular Templates (MTEM) United States $0.528B 0.00
Ardelyx (ARDX) United States $0.505B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.476B 0.00
Altimmune (ALT) United States $0.472B 0.00
Harpoon Therapeutics (HARP) United States $0.431B 0.00
Organogenesis Holdings (ORGO) United States $0.401B 0.00
Akebia Therapeutics (AKBA) United States $0.400B 0.00
TherapeuticsMD (TXMD) United States $0.398B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.394B 19.67
Rigel Pharmaceuticals (RIGL) United States $0.383B 0.00
Redhill Biopharma (RDHL) Israel $0.369B 0.00
MEI Pharma (MEIP) United States $0.367B 0.00
DURECT (DRRX) United States $0.353B 0.00
PROFOUND MEDICL (PROF) Canada $0.343B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.338B 8.38
Innate Pharma SA (IPHYF) France $0.324B 0.00
IMV INC (IMV) Canada $0.321B 0.00
Xeris Pharmaceuticals (XERS) United States $0.304B 0.00
Jounce Therapeutics (JNCE) United States $0.297B 14.08
Concert Pharmaceuticals (CNCE) United States $0.296B 0.00
Aquestive Therapeutics (AQST) United States $0.285B 0.00
Menlo Therapeutics (VYNE) United States $0.285B 0.00
Rafael Holdings (RFL) United States $0.273B 0.00
Calithera Biosciences (CALA) United States $0.257B 0.00
Lannett Co Inc (LCI) United States $0.245B 5.68
KalVista Pharmaceuticals (KALV) United States $0.241B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.223B 0.00
Nature's Sunshine Products (NATR) United States $0.222B 21.92
Avadel Pharmaceuticals (AVDL) Ireland $0.219B 0.00
Heat Biologics (HTBX) United States $0.209B 0.00
Taiwan Liposome (TLC) Taiwan $0.193B 0.00
CASI Pharmaceuticals (CASI) United States $0.191B 0.00
Nivalis Therapeutics (ALPN) United States $0.188B 0.00
OptiNose (OPTN) United States $0.188B 0.00
Otonomy (OTIC) United States $0.171B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.159B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.158B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.134B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.117B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Aclaris Therapeutics (ACRS) United States $0.107B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.105B 0.00
Lipocine (LPCN) United States $0.102B 0.00
Hemispherx BioPharma (AIM) United States $0.101B 0.00
MediWound (MDWD) Israel $0.097B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.083B 0.00
Biomerica (BMRA) United States $0.081B 0.00
CTI BioPharma (CTIC) United States $0.081B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.079B 0.00
ElectroCore (ECOR) United States $0.079B 0.00
Novan (NOVN) United States $0.076B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.074B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.072B 0.00
Addex Therapeutics (ADXN) Switzerland $0.070B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Onconova Therapeutics (ONTX) United States $0.057B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.057B 0.00
Recro Pharma (REPH) United States $0.054B 0.00
CV Sciences (CVSI) United States $0.054B 0.00
SCYNEXIS (SCYX) United States $0.052B 0.00
KemPharm (KMPH) United States $0.050B 0.00
Natural Alternatives (NAII) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 29.91
India Globalization Capital (IGC) United States $0.049B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.047B 0.00
GTx (ONCT) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
IsoRay (ISR) United States $0.040B 0.00
PolarityTE (PTE) United States $0.040B 0.00
ProPhase Labs (PRPH) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.93
AgeX Therapeutics (AGE) United States $0.033B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
Sundial Growers (SNDL) Canada $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Vical (BBI) United States $0.023B 0.00
Regulus Therapeutics (RGLS) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 24.09
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
JanOne (JAN) United States $0.009B 0.00
China SXT Pharmaceuticals (SXTC) China $0.008B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00